.Nature Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view requires addition of clients with MASLD and also size of liver end results in cardio-- renal-- metabolic tests, when data advise mechanistically conceivable advantages and scientific safety-- as well as summarizes considerations for trial concept as well as governing approval.